On Wednesday we presented the results from our collaboration with Janssen Research & Development at the Australasian Diabetes Congress. These results, announced to the ASX on the 16th July, demonstrate there is a potential therapeutic treatment for the at-risk patients identified by PromarkerD, our world-first predictive test for diabetic kidney disease.A copy of the conference presentation is attached.Following this presentation at the conference, Proteomics International will also be making a public media release about these ground-breaking results to the news services in Europe and the US.
Public Media Release to Europe & U S
Boom time not far away friends
On Wednesday we presented the results from our collaboration...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $49.87M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $201.7K | 642.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3253 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 57411 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |